<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LUP</journal-id>
<journal-id journal-id-type="hwp">splup</journal-id>
<journal-id journal-id-type="nlm-ta">Lupus</journal-id>
<journal-title>Lupus</journal-title>
<issn pub-type="ppub">0961-2033</issn>
<issn pub-type="epub">1477-0962</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0961203313476362</article-id>
<article-id pub-id-type="publisher-id">10.1177_0961203313476362</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Electroconvulsive therapy (ECT) for catatonia: delay may be risky</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nazarian</surname><given-names>RS</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Liebman</surname><given-names>LS</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kellner</surname><given-names>CH</given-names></name>
<xref ref-type="corresp" rid="corresp1-0961203313476362"/>
</contrib>
</contrib-group>
<aff id="aff1-0961203313476362">Mount Sinai School of Medicine, Psychiatry, NY, USA</aff>
<author-notes>
<corresp id="corresp1-0961203313476362">CH Kellner, Department of Psychiatry, Mount Sinai School of Medicine 1 Gustave L Levy Place, Psychiatry Box 1230 New York, NY 10029 USA. Email: <email>charles.kellner@mssm.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>22</volume>
<issue>3</issue>
<fpage>336</fpage>
<lpage>336</lpage>
<history>
<date date-type="received"><day>5</day><month>12</month><year>2012</year></date>
<date date-type="accepted"><day>3</day><month>1</month><year>2013</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2013. Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Sir,</p>
<p>We read with great interest the superbly presented case “The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia”.<sup><xref ref-type="bibr" rid="bibr1-0961203313476362">1</xref></sup> The authors comprehensively document the patient’s complex medical and neuropsychiatric illness. The case highlights how difficult the ultimate diagnosis of catatonia may be in a non-psychiatric patient. Despite appropriate management, recommendation for electroconvulsive therapy (ECT) was delayed for three months as is often the case. Such delay is not without risk; catatonic patients are predisposed to a wide variety of medical complications, many of which may be serious, even lethal. As early as 1977 Regestein et al. described fatal outcomes in two patients with catatonia, warning that catatonic stupor can “lead to fatal complications, and aggressive medical and psychiatric therapy is indicated”.<sup><xref ref-type="bibr" rid="bibr2-0961203313476362">2</xref></sup> As recently as 2012, a death due to the delayed implementation of ECT in a catatonic patient has been reported.<sup><xref ref-type="bibr" rid="bibr3-0961203313476362">3</xref></sup> Other medical complications that have been reported in association with catatonia include pulmonary emboli,<sup><xref ref-type="bibr" rid="bibr4-0961203313476362">4</xref></sup> pneumonia,<sup><xref ref-type="bibr" rid="bibr5-0961203313476362">5</xref></sup> and contractures.<sup><xref ref-type="bibr" rid="bibr6-0961203313476362">6</xref></sup> The full spectrum of medical complications in catatonic patients has recently been reviewed.<sup><xref ref-type="bibr" rid="bibr7-0961203313476362">7</xref></sup> “Malignant catatonia” refers to a particularly severe syndrome of catatonic features and autonomic instability that has a high mortality rate if not aggressively treated; ECT may be considered the treatment of choice for this condition.<sup><xref ref-type="bibr" rid="bibr8-0961203313476362">8</xref></sup> Mon et al. described the use of right unilateral (RUL) ECT in their patient, and this is a helpful addition to the literature about the efficacy of this type of ECT. We continue to believe, however, that in urgently ill patients, for whom transient cognitive impairment is a secondary consideration, bilateral ECT at substantially suprathreshold stimulus dosing remains the technique of choice.<sup><xref ref-type="bibr" rid="bibr9-0961203313476362">9</xref></sup> While ECT is rarely recommended for children and adolescents, when appropriate indications are present, there is no reason to consider age an impediment to its use.<sup><xref ref-type="bibr" rid="bibr10-0961203313476362">10</xref></sup> Fortunately for Mon et al.’s patient, a three-month delay did not prevent an excellent outcome; however, we strongly urge early consideration of ECT, when appropriate, to avoid medical complications resulting from prolonged catatonia.</p>
</body>
<back>
<sec id="sec1-0961203313476362"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0961203313476362"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mon</surname><given-names>T</given-names></name><name><surname>L'Ecuyer</surname><given-names>S</given-names></name><name><surname>Farber</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia</article-title>. <source>Lupus</source> <year>2012</year>; <volume>21</volume>: <fpage>1575</fpage>–<lpage>1581</lpage>.</citation></ref>
<ref id="bibr2-0961203313476362"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Regestein</surname><given-names>QR</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Reich</surname><given-names>P</given-names></name></person-group>. <article-title>Sudden catatonic stupor with disastrous outcome</article-title>. <source>JAMA</source> <year>1977</year>; <volume>238</volume>: <fpage>618</fpage>–<lpage>620</lpage>.</citation></ref>
<ref id="bibr3-0961203313476362"><label>3</label><citation citation-type="other"><comment>Belaizi M, Yahia A, Mehssani J, Bouchikhi Idrissi ML, Bichra MZ. Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics. <italic>Encephale</italic>. Epub ahead of print. Oct 11 2012. DOI: 10.1016/j.encep.2012.06.032</comment>.</citation></ref>
<ref id="bibr4-0961203313476362"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>HH</given-names></name><name><surname>Ritchie</surname><given-names>JC</given-names></name><name><surname>McNutt</surname><given-names>MD</given-names></name><name><surname>Musselman</surname><given-names>DL</given-names></name></person-group>. <article-title>Pulmonary embolism in a patient with catatonia: An old disease, changing times</article-title>. <source>Psychosomatics</source> <year>2011</year>; <volume>52</volume>: <fpage>387</fpage>–<lpage>391</lpage>.</citation></ref>
<ref id="bibr5-0961203313476362"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swartz</surname><given-names>C</given-names></name><name><surname>Galang</surname><given-names>RL</given-names></name></person-group>. <article-title>Adverse outcome with delay in identification of catatonia in elderly patients</article-title>. <source>Am J Geriatr Psychiatry</source> <year>2001</year>; <volume>9</volume>: <fpage>78</fpage>–<lpage>80</lpage>.</citation></ref>
<ref id="bibr6-0961203313476362"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>S</given-names></name><name><surname>Behere</surname><given-names>RV</given-names></name><name><surname>Varambally</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>NP</given-names></name><name><surname>Venkatasubramanian</surname><given-names>G</given-names></name><name><surname>Gangadhar</surname><given-names>BN</given-names></name></person-group>. <article-title>Physical deformity as sequela of chronic catatonia and response to electroconvulsive therapy: A case report</article-title>. <source>J ECT</source> <year>2011</year>; <volume>27</volume>: <fpage>e49</fpage>–<lpage>e50</lpage>.</citation></ref>
<ref id="bibr7-0961203313476362"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaimes-Albornoz</surname><given-names>W</given-names></name><name><surname>Serra-Mestres</surname><given-names>J</given-names></name></person-group>. <article-title>Catatonia in the emergency department</article-title>. <source>Emerg Med J</source> <year>2012</year>; <volume>29</volume>: <fpage>863</fpage>–<lpage>867</lpage>.</citation></ref>
<ref id="bibr8-0961203313476362"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>MA</given-names></name></person-group>. <article-title>Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> <year>2006</year>; <volume>30</volume>: <fpage>1182</fpage>–<lpage>1183; author reply 1184–1185</lpage>.</citation></ref>
<ref id="bibr9-0961203313476362"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kellner</surname><given-names>CH</given-names></name><name><surname>Popeo</surname><given-names>DM</given-names></name><name><surname>Aloysi</surname><given-names>AS</given-names></name></person-group>. <article-title>Electroconvulsive therapy for catatonia</article-title>. <source>Am J Psychiatry</source> <year>2010</year>; <volume>167</volume>: <fpage>1127</fpage>–<lpage>1128; author reply 1128</lpage>.</citation></ref>
<ref id="bibr10-0961203313476362"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Kellner</surname><given-names>CH</given-names></name></person-group>. <article-title>When is electroconvulsive therapy appropriate for children and adolescents?</article-title> <source>Med Hypotheses</source> <year>2011</year>; <volume>76</volume>: <fpage>395</fpage>–<lpage>399</lpage>.</citation></ref>
</ref-list>
</back>
</article>